“China’s announcement of a clinical trial came a little bit earlier than I had expected, even though I believe the first dose of the recombinant vaccine has already been injected into Chen’s body and some of her teammates,” Tao Lina, a Shanghai-based vaccine expert, said.
Tao was referring to photos that have been circulating on the social media platform WeChat that showed Chen being injected with a possible vaccine.
China developing 9 potential vaccines in global race for coronavirus cure
19 Mar 2020
Chen, 54 specialises in the development of recombinant vaccines – which use a harmless virus or bacterium to introduce the pathogen’s genetic material into the body to build up immunity – and has been credited with helping develop treatments during the 2014-16 Ebola outbreak.
She also developed a nasal spray to protect medical workers during the 2002-03 outbreak of severe acute respiratory syndrome (Sars).
The Chinese military has also been helping to tackle the medical emergency in Hubei, the province at the centre of the outbreak, with more than 10,000 personnel being deployed.
Actually it’s only 6% who stated that they definitely would not.
That's hardly news given that the country voted for Brexit.
But for some reason your link doesn't, even though it seems correct. Try copying
Code: Select all
https://www.thelancet.com/lancet/article/s0140-6736(20)31604-4They were f.cking brackets when they left here.
It's a good question, and I don't know if this helpsdiscovolante wrote: ↑Mon Jul 20, 2020 10:06 pmCan someone who is more knowledgeable than me explain how a vaccine would overcome the apparent fact that antibodies from infection don't seem to be lasting that long? Asks she who knows very little about vaccines despite 12 years hanging around here.
Looks like the name of Elon Musk's next child.sTeamTraen wrote: ↑Mon Jul 20, 2020 11:59 pmThe vaccine is called "ChAdOx1 nCoV-19", which I presume is what happens when you let your 12-year-old son and his pals name it.
Thank you, I'll have a read through that link later.Gfamily wrote: ↑Mon Jul 20, 2020 10:23 pmIt's a good question, and I don't know if this helpsdiscovolante wrote: ↑Mon Jul 20, 2020 10:06 pmCan someone who is more knowledgeable than me explain how a vaccine would overcome the apparent fact that antibodies from infection don't seem to be lasting that long? Asks she who knows very little about vaccines despite 12 years hanging around here.
https://www.technologynetworks.com/immu ... ces-293550
tl:dr is that the vaccine causes not only an immediate creation of antibodies by B cells, but also the development of 'Memory B cells', which mean the body can make a much faster response to future infection
The UK government has pre-ordered 100 million doses. I presume it will go to Michael Gove and his family first, then healthcare workers, then be offered to people over 65 or those with other pre-existing conditions. Maybe also schoolteachers?Herainestold wrote: ↑Tue Jul 21, 2020 3:56 pmHow will they decide who gets it, if and when it becomes available?
There seems to be a school of thought that we'll be needing revaccination.discovolante wrote: ↑Mon Jul 20, 2020 10:06 pmCan someone who is more knowledgeable than me explain how a vaccine would overcome the apparent fact that antibodies from infection don't seem to be lasting that long? Asks she who knows very little about vaccines despite 12 years hanging around here.
Prof Sir John Bell, of the University of Oxford, said he thought it was unlikely that Covid-19 would ever be eliminated [...] "The vaccine is unlikely to have a durable effect that'll last for a very long time, so we're going to have to have a continual cycle of vaccinations, and then more disease, and more vaccinations and more disease."
It uses a chimpanzee adenovirus developed at Oxford as a base. There are two of these, and it uses number 1. It combats a novel Coronavirus first seen in 2019. So, yes, naming may well have involved 12-year olds.sTeamTraen wrote: ↑Mon Jul 20, 2020 11:59 pmThe vaccine is called "ChAdOx1 nCoV-19", which I presume is what happens when you let your 12-year-old son and his pals name it.
Don’t tell the antivaxxers. As soon as they hear about humans being injected with a monkey virus they’ll go apeshit.Millennie Al wrote: ↑Wed Jul 22, 2020 2:21 amIt uses a chimpanzee adenovirus developed at Oxford as a base. There are two of these, and it uses number 1. It combats a novel Coronavirus first seen in 2019. So, yes, naming may well have involved 12-year olds.sTeamTraen wrote: ↑Mon Jul 20, 2020 11:59 pmThe vaccine is called "ChAdOx1 nCoV-19", which I presume is what happens when you let your 12-year-old son and his pals name it.
Some details at https://www.vaccitech.co.uk/technology/
Do not rhesusitate?Woodchopper wrote: ↑Wed Jul 22, 2020 3:49 amDon’t tell the antivaxxers. As soon as they hear about humans being injected with a monkey virus they’ll go apeshit.Millennie Al wrote: ↑Wed Jul 22, 2020 2:21 amIt uses a chimpanzee adenovirus developed at Oxford as a base. There are two of these, and it uses number 1. It combats a novel Coronavirus first seen in 2019. So, yes, naming may well have involved 12-year olds.sTeamTraen wrote: ↑Mon Jul 20, 2020 11:59 pmThe vaccine is called "ChAdOx1 nCoV-19", which I presume is what happens when you let your 12-year-old son and his pals name it.
Some details at https://www.vaccitech.co.uk/technology/
Very goodheadshot wrote: ↑Wed Jul 22, 2020 6:07 amDo not rhesusitate?Woodchopper wrote: ↑Wed Jul 22, 2020 3:49 amDon’t tell the antivaxxers. As soon as they hear about humans being injected with a monkey virus they’ll go apeshit.